Citations

Clear

2014 citation(s) found for "Lu, Patricia G".

Evaluation of the DISQVER metagenomic sequencing platform for detection of microbial cell-free DNA in plasma and cerebrospinal fluid
Cox, Christina R , Norgan, Andrew P , Yao, Joseph D. , Patel, Robin , Simner, Patricia J

Mayo Clinic

Journal of Clinical Microbiology | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1128/jcm.01037-26 | PMID 43012523 Get It

Clinician Counseling and Patient Storage and Disposal Practices for Opioids Prescribed for Acute Pain: A Multicenter Prospective Cohort Study
Taherifard, Erfan , Ahadpour, Mitra , Chang, Nancy, Allen, Summer V. , Elie, Marie‐Carmelle , Fillmore, W. Jonathan , Gilbert, Gregg H. , Heckmann, Rebekah, Koussis, Patricia, Lee, Christine, Lipkind, Heather S. , Mallama, Celeste A. , Meyer, Tamra E. , Nuckols, Teryl K. , Ritchie, Jessica , Pacanowski, Michael , Page, David B. , Soukup, Mat, Tamang, Stephen, Torbati, Sam , Wallace, Doug, Walter, Lauren A. , Zhao, Yueqin, Shah, Nilay D. , Ross, Joseph S. , Jeffery, Molly Moore

Mayo Clinic

No container title available | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.11.04.26367278 Get It

ABSTRACT BACKGROUND Opioids prescribed for acute pain frequently remain unused, creating opportunities for unintended use, accidental ingestion, or diversion. Little is known about counseling patients receive from prescribers or pharmacists on storage and disposal of opioids. OBJECTIVE To characterize clinician counseling on opioid disposal and patient-reported storage, use, and disposal practices among opioid-naïve patients prescribed opioids for acute pain. DESIGN Multicenter prospective cohort study with participant recruitment between September 2020 and March 2023. PARTICIPANTS Opioid-naïve patients prescribed opioids for acute pain in emergency departments, primary care or urgent care clinics, inpatient settings, and dental practices. MAIN MEASURES Patient-reported receipt of counseling on the importance of opioid disposal and appropriate disposal methods; opioid storage practices; use and disposition of prescribed opioids; disposal methods; and reasons for keeping or disposing of leftover opioids. KEY RESULTS Among 1708 participants, the median age was 38 years (IQR, 28-52); most were recruited from emergency departments (n=915; 53.6%) and primary care or urgent care clinics (n=307; 18.0%). Among 1233 participants who answered the question on counseling about the importance of opioid disposal, 811 (65.8%) reported receiving no counseling. Among 1220 participants who answered the question on counseling about appropriate disposal methods, 832 (68.2%) reported receiving no counseling. Among 812 participants who answered the question about storing opioids in a locked location, 610 (75.1%) reported never doing so. Among 929 participants providing information on opioid leftovers and disposition, 618 (66.5%) did not use all prescribed opioids. Among these 618 participants, 258 (42.8%) kept leftover opioids and 345 (57.2%) disposed of them. Among 256 participants who reported reasons for keeping leftover opioids, 159 (62.1%) wanted medication available for the same condition, 70 (27.3%) wanted medication available for a different condition, and 36 (14.1%) did not know how to properly dispose of the medication. CONCLUSIONS Among opioid-naïve patients prescribed opioids for acute pain, counseling about opioid disposal was uncommon, secure storage was infrequent, and leftover opioids were frequent, with many patients keeping leftover opioids for possible future use. These findings suggest opportunities to improve counseling on opioid storage and disposal and encourage safe disposal of unused opioids after acute pain treatment.
Opioid prescribing and pain trajectories after periacetabular osteotomy
Guarin Perez, Sergio F , Restrepo, Diego J. , Tai, Ta-Wei , Hanson, Kristine , Habermann, Elizabeth , Sierra, Rafael J

Mayo Clinic

Bone & Joint Open | November 4, 2026 | Volume: 7 | Issue: 11 | Pages: 1410-1418

10.1302/2633-1462.711.bjo-2026-0191.r1 | PMID 42976904 Get It

Aims Periacetabular osteotomy (PAO) is performed in young, opioid-naive patients and is associated with postoperative pain. Optimizing perioperative analgesia while limiting opioid exposure remains a priority. This study evaluated postoperative pain trajectories, hospital length of stay (LOS), and opioid-prescribing patterns associated with an institutional transition from epidural-based to periarticular injection (PAI)-based analgesia after PAO. Secondary aims were to assess the influence of preoperative opioid exposure and compare outcomes between ropivacaine-based and bupivacaine PAI formulations. Methods The study included 724 patients who underwent PAO between January 2010 and December 2022 at a single academic institution, with epidural use replaced by PAI in 2016. Patients were stratified by postoperative analgesia strategy: epidural catheter (n = 333) or PAI (n = 391). Outcomes included daily postoperative pain scores, LOS, discharge opioid prescriptions (morphine milligram equivalents (MMEs)), total opioid exposure, and 30-day refill rates. Statistical comparisons were performed using chi-squared, Fisher’s exact, and Kruskal–Wallis tests. Results Baseline characteristics were similar between groups. Epidural analgesia was associated with lower pain scores during the first 48 hours (last pain postoperative day 0 to 1: mean 2.9 (SD 2.0) vs 4.7 (SD 2.1); p < 0.001), whereas the PAI group had a shorter LOS (mean 2.2 days (SD 1.0) vs 3.4 days (SD 0.9); p < 0.001) and higher pain scores at discharge (mean 4.8 (SD 1.9) vs 4.0 (SD 1.9); p < 0.001). Median discharge opioid prescriptions (313 (IQR 225 to 388) vs 825 (IQR 600 to 1,000) MMEs) and total 30-day opioid exposure (360 (IQR 275 to 575) vs 900 (IQR 638 to 1,100) MMEs) were lower in the PAI group (both p < 0.001), while refill rates were higher (34.0% vs 19.2%; p < 0.001). Within the PAI cohort, ropivacaine-based and bupivacaine injections showed similar pain trajectories and refill rates. Conclusion Epidural analgesia provided superior early postoperative pain control, whereas PAI-based pathways enabled earlier discharge and lower overall opioid prescribing but with higher refill rates. These findings highlight trade-offs in contemporary perioperative pathways and support individualized analgesic strategies after PAO. Cite this article: Bone Jt Open 2026;7(11):1410–1418.
United States Public Health Laboratory Experiences with Krabbe Disease Newborn Screening After Recommendation at the National Level
Culshaw-Klein, Zoë , Mestel, Kaegan, Kirschner, Alison La Pean , Brackbill, Lesa , Baker, Mei Wang , Hall, Patricia , White, Amy

Mayo Clinic

International Journal of Neonatal Screening | October 30, 2026 | Volume: 12 | Issue: 4 | Pages: 94

10.3390/ijns12040094 Get It

Krabbe disease (KD) is a rare, inherited leukodystrophy associated with early mortality. Infantile Krabbe disease (IKD) was added to the Recommended Uniform Screening Panel (RUSP) in July 2024. Since then, U.S. states have continued to evaluate implementing KD newborn screening (NBS), and RUSP inclusion has hastened adoption efforts. This study aimed to characterize NBS program responses to this recommendation and identify factors influencing adoption and implementation. A mixed-methods approach was used, including a case review of Wisconsin’s process to add conditions to its NBS panel and a cross-sectional survey of U.S. NBS programs. Responses were obtained from 50 of 51 NBS programs. Twenty-two programs actively screen for KD, with ten additional programs in the implementation process. Screening approaches varied, particularly in psychosine (PSY) cutoff thresholds and testing algorithms. Programs reported a range of adoption pathways, including legislative mandates, advisory committee review, and state-specific nomination processes. Key factors impacting KD NBS adoption included uncertainty regarding treatment safety, efficacy, and availability, ethical considerations related to identifying later-onset disease, and logistical challenges such as laboratory readiness and clinical follow-up resources. This study provides a contemporary overview of national implementation of KD NBS and offers practical insights for programs considering adoption.
Reply to Edelstein, “Does Legionella 5S rRNA PCR melting temperature analysis discriminate high-risk species and increased disease severity or does it simply reflect test selection bias?”
Khattar, Georges , Patel, Robin , Simner, Patricia J

Mayo Clinic

Journal of Clinical Microbiology | October 27, 2026 | Volume: 64 | Issue: 11 | Pages: No page available

10.1128/jcm.01077-26 | PMID 42937356 Get It

Genetic Heterogeneity of Asthma Across Sex, Age at Onset, and Disease Severity
Kyriakidou, Maria , Silveyra, Patricia , Kling, Juliana M , Gaston, Benjamin , Fernandez, Gerry, Keswani, Shiwani, Nixon, Lacey, Zein, Joe G

Mayo Clinic

Clinical & Experimental Allergy | October 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/cea.70466 | PMID 42933388 Get It

Summary Asthma genetic architecture varies according to age at onset and biological sex. Medication‐defined severity showed limited common variant genetic heterogeneity compared with age at onset and sex.
The Pros & Cons of Measuring Plasma Ammonia in the Management of Patients With Cirrhosis: An ISHEN Debate
Ballester, Maria Pilar , Bloom, Patricia, Rose, Christopher F

Mayo Clinic

Liver International | October 23, 2026 | Volume: 46 | Issue: 11 | Pages: No page available

10.1111/liv.70904 | PMID 42922100 Get It

ABSTRACT Ammonia is a nitrogenous molecule which is primarily generated in the gastrointestinal tract. The neurotoxicity of ammonia plays a critical role in the liver's regulation of circulating ammonia levels. In liver disease, an increase in blood ammonia has been long implicated in the pathogenesis of hepatic encephalopathy (HE), a neurological complication of liver disease. However, the clinical value of measuring plasma ammonia in patients with cirrhosis remains controversial. This dilemma was the subject of a debate held at the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) meeting in St‐Paulin, Québec, Canada in October 2025. This review illustrates the pros & cons of measuring plasma ammonia in the management of patients with cirrhosis.
Transforming Adverse Event Response: A Narrative Systematic Review of Healthcare Communication-And-Resolution Program Outcomes, Barriers, and Recommendations
Unruh, Maggie A. , Carranza, Leslie , Carmack, Heather J

Mayo Clinic

Health Communication | October 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-15

10.1080/10410236.2026.2750879 | PMID 42895179 Get It

Disagreement Between Outpatient Complications in the USNWR ENT Ratings and Clinical Adjudication
Pollock, Benjamin D , Anderson, Stephanie S., Vaver, Anne M, Devkaran, Subashnie, Tasche, Kendall K.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ohn.70494 | PMID 42867264 Get It

Abstract Objective In 2024, the US News and World Report (USNWR)'s Best Hospitals began reporting complications following elective outpatient otolaryngology procedures in its ears, nose, and throat (ENT) ranking. However, this methodology has not been clinically adjudicated in a peer‐reviewed domain. We aimed to conduct manual health record adjudication to assess whether the USNWR methodology accurately attributes complications following elective outpatient otolaryngology procedures. Study Design Case‐cohort. Setting A case‐cohort of n = 80 elective, outpatient otolaryngology procedure/complication pairings from January 2019 to October 2023 across four academic medical centers using the 2024 USNWR otolaryngology procedure subgroups and Solventum Ambulatory Potentially Preventable Complications (AM‐PPC) software. Methods We used the AM‐PPC‐defined complication types as our standard of comparison for our clinical adjudication. Using the electronic health record, we adjudicated: (1) Was there agreement (yes/no) on complication type between our clinical adjudication and the Solventum AM‐PPC software? (2) Was the complication clinically related to, or a sequela of, the index otolaryngology procedure (yes/no)? Results The clinical adjudication agreed on complication type in 59/80 (74%) of patients, and 63/80 (79%) were judged to be clinically related to the index otolaryngology procedure. In total, 50/80 (63%) complications were adjudicated to be in agreement on both the complication type and clinical relatedness to the index procedure, while 9/80 (11%) complications did not agree with the complication type nor were clinically related to the index procedure. Conclusion Outpatient complications reported in the USNWR ENT rating lack the specificity to exclude patients whose complications are sequelae of chronic underlying conditions or related to concurrent, non‐otolaryngology procedures.
Assessment of Fairness and Bias of an Image-based Surgical Site Infection Detection AI Model
Lee, Frank G. , Choudhary, Ashok , Li-Han, Leo Yan , Dale, Erica L., Bankes, Audrey C , Varghese, Chris , Anderson, Stephanie S., Habermann, Elizabeth B. , Etzioni, David A. , McLaughlin, Sarah A. , Salehinejad, Hojjat , Thiels, Cornelius A. , Varghese, Chris , Habermann, Elizabeth , Dale, Erica , Bankes, Audrey , Choudhary, Ashok , Lee, Frank G

Mayo Clinic

No container title available | September 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.22.26363636 Get It

ABSTRACT Background Evaluating fairness in artificial intelligence (AI) is essential before clinical implementation to prevent unintended harm across diverse patient populations. This study assesses performance differences of an image-based surgical site infection (SSI) detection model across age, gender, geography, race, and skin color. Methods Model development/validation study using retrospective, multicenter data across surgical subspecialties from adults who submitted an image of their incision via the electronic health record within 30 days of their procedure between 2019-2024. Area under receiver operating curve (AUROC) was compared by age (<55 vs. ≥55 years old), gender (male vs. female), geography (Rochester, Minnesota vs. Jacksonville, Florida vs. Scottsdale, Arizona vs. regional Minnesota/Wisconsin areas), race (White/Caucasian vs. non-White/Caucasian), and skin color (Fitpatrick I-III vs. IV-VI and Monk A-E vs. F-J). Results Training data contained 13,702 images from 4,274 patients between 2019-2022 (50.1% ≥55 years old; 63.2% female; 91.6% White/Caucasian; 58.5% Rochester, 17.3% Florida, 10.5% Arizona; 96.3% light skin tone), of which 1,348 images (9.8%) had an SSI. No differences in SSI detection existed for age, gender, race, or skin color (AUROC 0.83-0.87, p>0.09), however geographical differences were significant: lowest AUROC 0.83 (95% CI 0.77-0.88) vs. highest AUROC 0.87 (95% CI 0.84-0.89, p=0.01). Temporal validation using 4,242 images from 1,353 patients between 2022-2023 showed intact fairness across subgroups (ΔAUROC ≤0.06) except geography (ΔAUROC ≤0.16). Conclusions The model behaved fairly across age, gender, race, and skin color, however geographical differences persisted. These findings have practical implications underscoring the importance of evaluating bias in clinical AI before deployment.